DK1205190T3 - Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider - Google Patents

Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider

Info

Publication number
DK1205190T3
DK1205190T3 DK00948291T DK00948291T DK1205190T3 DK 1205190 T3 DK1205190 T3 DK 1205190T3 DK 00948291 T DK00948291 T DK 00948291T DK 00948291 T DK00948291 T DK 00948291T DK 1205190 T3 DK1205190 T3 DK 1205190T3
Authority
DK
Denmark
Prior art keywords
drug
stable pharmaceutical
present
pharmaceutical compositions
oral administration
Prior art date
Application number
DK00948291T
Other languages
Danish (da)
English (en)
Inventor
Kazuhiro Sako
Toyohiro Sawada
Keiichi Yoshihara
Tatsunobu Yoshioka
Shunsuke Watanabe
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1205190(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK1205190T3 publication Critical patent/DK1205190T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00948291T 1999-08-04 2000-08-01 Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider DK1205190T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14722299P 1999-08-04 1999-08-04

Publications (1)

Publication Number Publication Date
DK1205190T3 true DK1205190T3 (da) 2006-08-14

Family

ID=22520720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00948291T DK1205190T3 (da) 1999-08-04 2000-08-01 Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider

Country Status (17)

Country Link
EP (1) EP1205190B1 (zh)
JP (1) JP3462490B2 (zh)
KR (1) KR100507400B1 (zh)
CN (1) CN1193792C (zh)
AT (1) ATE324909T1 (zh)
AU (1) AU769807B2 (zh)
CA (1) CA2387705C (zh)
DE (1) DE60027728T2 (zh)
DK (1) DK1205190T3 (zh)
ES (1) ES2262528T3 (zh)
HU (1) HU229295B1 (zh)
MX (1) MXPA02001267A (zh)
NO (1) NO331834B1 (zh)
PL (1) PL200645B1 (zh)
PT (1) PT1205190E (zh)
RU (1) RU2220715C2 (zh)
WO (1) WO2001010466A1 (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232805A1 (en) * 2002-04-24 2003-12-18 Cypress Bioscience, Inc. Prevention and treatment of functional somatic disorders, including stress-related disorders
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
JP2012515757A (ja) * 2009-01-20 2012-07-12 マイクロ ラブス リミテッド トリメタジジンの放出調節固形薬剤組成物及びその製造方法
EP2456427B1 (en) 2009-07-22 2015-03-04 Grünenthal GmbH Hot-melt extruded controlled release dosage form
AR077420A1 (es) 2009-07-22 2011-08-24 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion
PL2554168T3 (pl) 2010-03-29 2018-05-30 Astellas Pharma Inc. Kompozycja farmaceutyczna do kontrolowanego uwalniania
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
KR102027912B1 (ko) 2011-02-15 2019-10-02 지엘팜텍주식회사 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
EP2838512B1 (en) 2012-04-18 2018-08-22 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
WO2016148264A1 (ja) * 2015-03-19 2016-09-22 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
EA035434B1 (ru) 2015-04-24 2020-06-15 Грюненталь Гмбх Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
TWI722988B (zh) 2015-06-05 2021-04-01 瑩碩生技醫藥股份有限公司 緩釋性醫藥組合物及其製備方法
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
SI3360866T1 (sl) 2017-02-14 2019-04-30 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Mirabegronska predzdravila
EP3722285B1 (en) 2020-04-08 2022-03-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Process for preparing mirabegron enacarbil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
CA2218054C (en) * 1995-04-14 2005-10-18 Pharma Pass Solid compositions containing polyethylene oxide and an active ingredient
DK0991409T3 (da) * 1997-08-01 2002-03-25 Elan Corp Plc Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse
ATE241341T1 (de) * 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd Stabilisierte pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
MXPA02001267A (es) 2002-08-12
KR20020046277A (ko) 2002-06-20
NO20020516D0 (no) 2002-02-01
JP3462490B2 (ja) 2003-11-05
KR100507400B1 (ko) 2005-08-10
EP1205190B1 (en) 2006-05-03
CN1193792C (zh) 2005-03-23
CA2387705C (en) 2009-06-30
RU2220715C2 (ru) 2004-01-10
CN1373673A (zh) 2002-10-09
HU229295B1 (en) 2013-10-28
PT1205190E (pt) 2006-09-29
NO20020516L (no) 2002-02-01
EP1205190A1 (en) 2002-05-15
DE60027728D1 (de) 2006-06-08
AU769807B2 (en) 2004-02-05
ES2262528T3 (es) 2006-12-01
HUP0202495A2 (hu) 2002-11-28
PL353154A1 (en) 2003-10-20
PL200645B1 (pl) 2009-01-30
ATE324909T1 (de) 2006-06-15
HUP0202495A3 (en) 2004-05-28
AU6182100A (en) 2001-03-05
WO2001010466A1 (fr) 2001-02-15
DE60027728T2 (de) 2007-04-26
EP1205190A4 (en) 2004-01-21
CA2387705A1 (en) 2001-02-15
NO331834B1 (no) 2012-04-16

Similar Documents

Publication Publication Date Title
DK1205190T3 (da) Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider
RU2002102701A (ru) Стабильная пероральная образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
TR200001810A3 (tr) Hemen Eriyen Oral Dozaj Formülasyonu.
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
DE69212882T2 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
ATE108650T1 (de) Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken.
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
DK0673649T3 (da) Farmaceutiske sammensætninger til forlænget frisætning af trimetazidin efter oral administrering
PT1138333E (pt) Composicao farmaceutica oral
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
ATE371441T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE60129082D1 (de) Therapeutische Zusammensetzungen welche einen Überschuss eines Amlodipin-Enantiomers enthalten
DK598288D0 (da) Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen
DK1154776T3 (da) Farmaceutisk sammensætning, indeholdende desoxypeganin til behandling af alkoholisme
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ES2117114T3 (es) Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
ATE121297T1 (de) Neue polycarbophil enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
DE69403606D1 (de) Cyclizierte Analoge der Fettsäurenmetaboliten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
KR920017651A (ko) 오메프라졸 직장투여조성물